H.C. Wainwright initiated coverage on Oncolytics Biotech with a new price target

2/17/21 2:20:07 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

H.C. Wainwright initiated coverage of Oncolytics Biotech with a rating of Buy and set a new price target of $15.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ONCY

Date	Price Target	Rating	Analyst
10/6/2022	$3.00	Buy	Maxim Group